Incidence of osteonecrosis of the jaw (ONJ) in myeloma patients treated with bisphosphonates.
| Study . | No. Patients Treated with Bisphosphonates . | No. Patients with Suspected or Proven ONJ . | Incidence (%) . |
|---|---|---|---|
| Durie et al10 Web-based retrospective survey | 904 | 116 | 12.8% |
| Badros et al9 | 340 | 11 | 3.2% |
| Pozzi et al11 Italian Multicenter study—retrospective questionnaire | 888 | 16 | 1.8% |
| Tosi et al12 Retrospective analysis of Bologna 2002 trial | 225 | 6 | 2.7% |
| Cafro et al13 | 104 | 13 | 12.5% |
| Dimopoulos et al14 | 202 | 15 | 7.4% |
| Study . | No. Patients Treated with Bisphosphonates . | No. Patients with Suspected or Proven ONJ . | Incidence (%) . |
|---|---|---|---|
| Durie et al10 Web-based retrospective survey | 904 | 116 | 12.8% |
| Badros et al9 | 340 | 11 | 3.2% |
| Pozzi et al11 Italian Multicenter study—retrospective questionnaire | 888 | 16 | 1.8% |
| Tosi et al12 Retrospective analysis of Bologna 2002 trial | 225 | 6 | 2.7% |
| Cafro et al13 | 104 | 13 | 12.5% |
| Dimopoulos et al14 | 202 | 15 | 7.4% |